Full-Time

Manager – Contract Management

Updated on 6/13/2025

Deadline 6/19/25
Pfizer

Pfizer

10,001+ employees

Develops and manufactures biopharmaceuticals and vaccines

Compensation Overview

$96.3k - $160.5k/yr

+ Bonus

Mid, Senior

No H1B Sponsorship

Tampa, FL, USA + 2 more

More locations: Highland Park, IL, USA | New York, NY, USA

Position is hybrid and will require 2 to 3 days a week to work from site. Not eligible for relocation package.

Category
Management Consulting
Consulting
Required Skills
Word/Pages/Docs
Data Analysis
Excel/Numbers/Sheets
Requirements
  • Applicants must have a bachelor’s degree with 4+ years of experience OR a master’s degree with 2+ years of experience OR PhD OR an associate degree with 8+ years of experience OR a High School diploma (or equivalent) with 10+ years of relevant experience.
  • Relevant work experience in the pharmaceutical industry, managed care, or contracting space is preferred.
  • Excellent interpersonal and communication skills; both written and verbal, to influence and develop customer relationships and offer guidance.
  • Strong proficiency in Microsoft Word, Excel, and PowerPoint.
  • Ability to perform mathematical calculations, ability to perform complex data analysis, read documents.
Responsibilities
  • Develop contractual proposals and agreements in support of Pfizer Business Unit and Product Brand team initiatives related to low - mid value and complexity customer agreements.
  • Devise low to mid value and complexity customer agreements that maximize product utilization and profitability while ensuring compliance with all laws and regulations, pricing guidelines, portfolio management and brand strategy.
  • Manage low to mid value and complexity executed agreements during their term; Develop amendments and communications to the customer.
  • Track contract lifecycle and product offerings, analyze contract performance, present customer performance results to team lead and cross-functional stakeholders.
  • Leverage knowledge of customers, markets, and Pfizer strategies to understand the impact of evolving contract strategies; maintain the integrity of the existing SOX compliant departmental controls, good documentation practices and contract governance, and lead conversion around contract recommendations with minimal support from team lead.
  • Lead projects with low to medium risk level, impacting Contracting Management and cross-functional teams. Demonstrate initiative and ownership in independently completing assigned projects to its completion; Projects may include Continuous Improvements, System Enhancements, and Test system functionality.
  • Build and foster relationships with many cross-functional teams such as Contract Development/Strategy, Legal, Trade, Sales, Account Management, Product Brand Teams, Compliance, Contract Administration/Operations, Business Technology, Gov’t Pricing, Customer Service, Global Financial Services, Corporate Finance, Customer Analytics, and the Pfizer Business Units, to successfully manage contract management lifecycle for the high value and complex.
Desired Qualifications
  • Comfortable working under critical deadlines, and the ability to manage multiple tasks simultaneously.
  • Comfortable with ambiguity; ability to act without having the total picture.
  • Has previous exposure to Pfizer contracting systems (Flex and BO) or has demonstrated the ability to learn new systems.

Pfizer is a biopharmaceutical company that focuses on creating and producing healthcare products, including medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold globally. Pfizer's products include vaccines, oncology treatments, and other specialized medicines, with a significant role in developing a vaccine for COVID-19 in partnership with BioNTech. What sets Pfizer apart from its competitors is its strong commitment to public health, demonstrated by efforts to provide vaccines to underserved populations and a continuous expansion of its product portfolio through new approvals. The goal of Pfizer is to improve health outcomes worldwide by delivering effective healthcare solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • €3.3 billion bond offering provides capital for research initiatives or acquisitions.
  • Starboard Value's $1 billion stake suggests potential strategic changes to enhance shareholder value.
  • Backing Promise Bio aligns with expanding into new therapeutic areas like autoimmune diseases.

What critics are saying

  • Increased competition from emerging biotech companies could impact Pfizer's market share.
  • Slowdown in COVID-19 vaccine demand poses a risk to Pfizer's revenue streams.
  • Shift towards AI-driven drug discovery may disrupt traditional R&D processes at Pfizer.

What makes Pfizer unique

  • Pfizer's partnership with BioNTech led to a highly effective COVID-19 vaccine.
  • Pfizer's investment in AI disease models enhances drug discovery and development.
  • Pfizer's strategic interest in TCR-based immunotherapies diversifies its oncology portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance

Company News

Stroock & Stroock & Lavan LLP
May 20th, 2025
Pfizer Completes €3.3 Billion Bond Offering

Simpson Thacher represented the underwriters, led by Goldman Sachs & Co. LLC, BNP PARIBAS, HSBC, Mizuho, among others in connection with a registered offering of €3.3 billion in Notes by Pfizer, Inc.’s (“Pfizer”) wholly-owned subsidiary, Pfizer Netherlands International Finance B.V. (the “Issuer”). The Notes were issued in four series with maturities ranging from 2029 to 2045, with proceeds intended to be used for general corporate purposes. The Notes are fully and unconditionally guaranteed on a senior unsecured basis by Pfizer.

Finsmes
Mar 5th, 2025
Trimtech Therapeutics Raises $31M in Seed Funding

Trimtech Therapeutics, a Cambridge, UK-based biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, raised $31M in Seed funding

Business Wire
Jan 16th, 2025
Normunity Closes $75 Million Series B Financing to Advance Lead Drug Program Into the Clinic and Broaden Pipeline of Novel Anti-Cancer Therapies Targeting Untapped Drug Mechanisms

Normunity, a biotechnology company creating novel anti-cancer therapies, today announced that it has closed a Series B financing for $75 million. The

TechCrunch
Oct 23rd, 2024
Promise Bio exits stealth backed by Pfizer and AstraZeneca | TechCrunch

The company has made it easier to test for different protein modifications which are critical to the treatment of autoimmune diseases.

The Wall Street Journal
Oct 7th, 2024
Exclusive | Activist Starboard Value Takes $1 Billion Stake in Pfizer

The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments had slowed.